Gopa Iyer

Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor

Dejan Juric, Pau Castel, Malachi Griffith et al. · Nature · 2014 · 561 citations · Full text

Signal Transduction, Clinical Resistance, Signaling Pathway +8

Oncogenic Activation of Pak1-Dependent Pathway of Macropinocytosis Determines BCG Entry into Bladder Cancer Cells

Gil Redelman‐Sidi, Gopa Iyer, David B. Solit et al. · Cancer Research · 2013 · 111 citations · Full text

Characterization of on-target adverse events caused by TRK inhibitor therapy

D. Liu, James Flory, Andrew Lin et al. · Annals of Oncology · 2020 · 82 citations · Full text

Trk Inhibitor Therapy, Pharmacology, Therapeutic Efficacy +6

A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumors

Gopa Iyer, Michael J. Morris, Dana E. Rathkopf et al. · Cancer Chemotherapy and Pharmacology · 2011 · 35 citations · Full text

Oncology, Solid Tumors, Adult Patients +7

Mismatch repair (MMR) detection in urothelial carcinoma (UC) and correlation with immune checkpoint blockade (ICB) response.

Gopa Iyer, François Audenet, Sumit Middha et al. · Journal of Clinical Oncology · 2017 · 34 citations

Immunology, Pathology, Immune Checkpoint Blockade +21